What is Intellia Therapeutics's common stock?

Intellia Therapeutics (NTLA) reported common stock of $12K in Q1 2026.

How has Intellia Therapeutics's common stock changed year-over-year?

Intellia Therapeutics's common stock increased by 20.0% year-over-year, from $10K to $12K.

What is the long-term trend for Intellia Therapeutics's common stock?

Over 5 years (2020 to 2025), Intellia Therapeutics's common stock has grown at a 11.4% compound annual growth rate (CAGR), from $7K to $12K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Intellia Therapeutics NTLA Common Stock

Common Stock at other companies

Ionis PharmaceuticalsIONS

300M0.0%

ALN

Alnylam PharmaceuticalsALNY

250M0.0%

CRISPR TherapeuticsCRSP

$3.12M+14.5%

Beam TherapeuticsBEAM

$1.03M+2.1%

Iovance Biotherapeutics, Inc.IOVA

$18K+28.6%

Viridian Therapeutics, Inc.VRDN

200M0.0%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's common stock?: Intellia Therapeutics (NTLA) reported common stock of $12K in Q1 2026.
How has Intellia Therapeutics's common stock changed year-over-year?: Intellia Therapeutics's common stock increased by 20.0% year-over-year, from $10K to $12K.
What is the long-term trend for Intellia Therapeutics's common stock?: Over 5 years (2020 to 2025), Intellia Therapeutics's common stock has grown at a 11.4% compound annual growth rate (CAGR), from $7K to $12K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).